AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2025
Dec 3, 2025
34519_dirs_2025-12-03_1324d697-1b46-4dc1-aeb4-eac4ba4b53a3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2025-12-02
Reporting Person: te Boekhorst Paul Francis Olivier (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-02 | Common Stock $0.10 par value per share | P | 3708 | $4.8686 | Acquired | 3708 | Direct |
| 2025-12-03 | Common Stock $0.10 par value per share | P | 2556 | $5.003 | Acquired | 6264 | Direct |
| 2025-12-03 | Common Stock $0.10 par value per share | P | 3521 | $5.0406 | Acquired | 9785 | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23